Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
Prospective ARNI Versus ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events after Myocardial Infarction
Principal Investigator (?)
Study Number
F18010
Summary
The purpose of this study is to evaluate the efficacy and safety of LCZ696 titrated to a target dose of 200 mg twice daily, compared to ramipril titrated to a target dose of 5 mg twice daily, in addition to conventional post-AMI treatment, in reducing the occurrence of composite endpoint of CV death, HF hospitalization and outpatient HF (time-to-first event analysis) in post-AMI patients with evidence of LV systolic dysfunction and/or pulmonary congestion, with no known prior history of chronic HF.. 
Phase (?)
Phase III
Sponsor (?)
Contact

Gaylin Petty

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0